New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad's Prolaris® Biopsy Test in Localized Prostate CancerGlobeNewsWire • 07/02/26
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New PublicationGlobeNewsWire • 06/23/26
Should You Add Myriad Genetics Stock to Your Portfolio Right Now?Zacks Investment Research • 06/09/26
Myriad (MYGN) Up 7.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/04/26
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026Zacks Investment Research • 06/02/26
Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its StockZacks Investment Research • 05/28/26
Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual MeetingGlobeNewsWire • 05/27/26
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)GlobeNewsWire • 05/26/26
Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Myriad (MYGN)Zacks Investment Research • 05/18/26
Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her LifeGlobeNewsWire • 05/15/26
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum BusinessGlobeNewsWire • 05/05/26
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care PlanGlobeNewsWire • 04/30/26
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026GlobeNewsWire • 04/28/26
Analysts Estimate Myriad Genetics (MYGN) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/28/26
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026GlobeNewsWire • 04/16/26
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in JapanGlobeNewsWire • 04/14/26
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual MeetingGlobeNewsWire • 04/09/26